| dc.contributor.author | Rodrigo, Gustavo J | |
| dc.contributor.author | Price, David B | |
| dc.contributor.author | Anzueto, Antonio | |
| dc.contributor.author | Singh, Dave | |
| dc.contributor.author | Altman, Pablo | |
| dc.contributor.author | Bader, Giovanni | |
| dc.contributor.author | Patalano, Francesco | |
| dc.contributor.author | Fogel, Robert | |
| dc.contributor.author | Kostikas, Konstantinos | |
| dc.date.accessioned | 2017-03-20T09:28:20Z | |
| dc.date.available | 2017-03-20T09:28:20Z | |
| dc.date.issued | 2017-03-17 | |
| dc.identifier.citation | Rodrigo , G J , Price , D B , Anzueto , A , Singh , D , Altman , P , Bader , G , Patalano , F , Fogel , R & Kostikas , K 2017 , ' LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD : a systematic review and meta-analysis ' International journal of chronic obstructive pulmonary disease , vol 12 , pp. 907—922 . DOI: 10.2147/COPD.S130482 | en |
| dc.identifier.issn | 1176-9106 | |
| dc.identifier.other | PURE: 95907295 | |
| dc.identifier.other | PURE UUID: 458b761c-058a-41aa-8d9c-bbcad3c6d21a | |
| dc.identifier.other | Scopus: 85016136622 | |
| dc.identifier.uri | http://hdl.handle.net/2164/8355 | |
| dc.description | Acknowledgments The meta-analysis work was performed by Guruprasad Rao KS and Sharanbasappa Durg of Molecular Connections (P) Ltd, Bangalore, India, under the guidance of the manuscript authors and Novartis Pharma AG (Basel, Switzerland). Medical writing assistance was provided by Colette O’Sullivan, PhD, of Scriva Medical Communications Ltd, a professional medical writer funded by Novartis. Development of the manuscript was supported by Novartis Pharma AG (Basel, Switzerland). The authors received no compensation related to the development of the manuscript. | en |
| dc.format.extent | 16 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | International journal of chronic obstructive pulmonary disease | en |
| dc.rights | This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms. https://creativecommons.org/licenses/by-nc/3.0/ | en |
| dc.subject | LABA/LAMA combinations | en |
| dc.subject | COPD | en |
| dc.subject | LAMA | en |
| dc.subject | LABA/ICS | en |
| dc.subject | meta-analysis | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD : a systematic review and meta-analysis | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen, Medicine, Medical Sciences & Nutrition, Other Applied Health Sciences | en |
| dc.description.status | Peer reviewed | en |
| dc.description.version | Publisher PDF | en |
| dc.identifier.doi | http://dx.doi.org/10.2147/COPD.S130482 | |
